Macdonald Michael C
Director at MED; Senior Vice President at XEROX CORP
- Sold, on record
- $10.3M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Oct 1, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- MEDMEDIFAST INCDirector
- XEROX CORPSenior Vice President
Sales by reason
0
Routine
4
Plan not stated
0
No plan
5
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- XEROX CORP113,100 shares
- MED78,825 shares
Shares sold, every Form 4 sale on record.
Timeline
- Oct 1, 2020Plan not stated
Sold 1.8% of their holdings
$827k5,000 shares at $165.37
- Jul 1, 2020Plan not stated
Sold 1.8% of their holdings
$694k5,000 shares at $138.84
- May 6, 2020Plan not stated
Sold 3.5% of their holdings
$1M10,000 shares at $101.08
- Mar 5, 2019Unusual
Sold 100% of their holdings
$2.5M18,825 shares at $131.19
- Mar 9, 2018Plan not stated
Sold 11.3% of their holdings
$3.5M40,000 shares at $86.71
- May 1, 2007Unusual
Sold 59.7% of their holdings
$610k33,100 shares at $18.43
- Feb 5, 2007Unusual
Sold 47.3% of their holdings
$346k20,000 shares at $17.28
- Aug 4, 2006Unusual
Sold 27.4% of their holdings
$227k16,000 shares at $14.20
- Jan 30, 2006Unusual
Sold 43% of their holdings
$616k44,000 shares at $14.00
9 of 9
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2020 | Oct 2, 2020 | MED | Director | Sold | 5,000 | $165.37 | $827k | 266,179 | SEC |
| Jul 1, 2020 | Jul 6, 2020 | MED | Director | Sold | 5,000 | $138.84 | $694k | 271,179 | SEC |
| Jun 16, 2020 | Jun 18, 2020 | MED | Director | Awarded | 1,083 | 276,179 | SEC | ||
| May 6, 2020 | May 8, 2020 | MED | Director | Sold | 10,000 | $101.08 | $1M | 275,096 | SEC |
| May 16, 2019 | May 28, 2019 | MED | Director | Gift | 19,600 | 9,800 | SEC | ||
| Apr 10, 2019 | Apr 12, 2019 | MED | Director | Gift | 1,175 | 294,896 | SEC | ||
| Mar 5, 2019 | Mar 7, 2019 | MED | Director | Sold | 18,825 | $131.19 | $2.5M | 296,071 | SEC |
| Feb 22, 2019 | Feb 26, 2019 | MED | Director | Awarded | 708 | 302,496 | SEC | ||
| Nov 8, 2018 | Feb 14, 2019 | MED | Director | Gift | 19,800 | 9,900 | SEC | ||
| Mar 9, 2018 | Mar 13, 2018 | MED | Director | Sold | 40,000 | $86.71 | $3.5M | 314,188 | SEC |
| Feb 7, 2018 | Feb 9, 2018 | MED | Director | Awarded | 1,280 | 354,188 | SEC | ||
| Dec 31, 2017 | Feb 9, 2018 | MED | Director | Withheld for tax | 15,200 | $69.81 | $1.1M | 352,908 | SEC |
| Feb 19, 2017 | Feb 21, 2017 | MED | Exec Chairman of the Board | Withheld for tax | 8,000 | $45.07 | $361k | 368,108 | SEC |
| Feb 16, 2017 | Feb 21, 2017 | MED | Exec Chairman of the Board | Awarded | 53,620 | 376,108 | SEC | ||
| Jan 2, 2017 | Jan 4, 2017 | MED | Exec Chairman of the Board | Withheld for tax | 17,000 | $41.63 | $708k | 322,488 | SEC |
| Feb 19, 2016 | Feb 23, 2016 | MED | Chief Executive Officer | Withheld for tax | 8,000 | $29.52 | $236k | 339,488 | SEC |
| Feb 4, 2016 | Feb 8, 2016 | MED | Chief Executive Officer | Awarded | 22,500 | 347,488 | SEC | ||
| Jan 2, 2016 | Jan 5, 2016 | MED | Chief Executive Officer | Withheld for tax | 16,000 | $30.38 | $486k | 324,988 | SEC |
| Feb 19, 2015 | Feb 23, 2015 | MED | Chief Executive Officer | Withheld for tax | 5,334 | $32.50 | $173k | 340,988 | SEC |
| Feb 17, 2015 | Feb 19, 2015 | MED | Chief Executive Officer | Awarded | 20,000 | 346,322 | SEC | ||
| Jan 2, 2015 | Jan 5, 2015 | MED | Chief Executive Officer | Withheld for tax | 20,000 | $33.03 | $661k | 326,322 | SEC |
| Oct 31, 2014 | Nov 3, 2014 | MED | Chief Executive Officer | Withheld for tax | 7,000 | $31.74 | $222k | 346,322 | SEC |
| Jun 30, 2014 | Jul 2, 2014 | MED | Chief Executive Officer | Withheld for tax | 7,000 | $30.41 | $213k | 353,322 | SEC |
| Jun 17, 2014 | Jun 19, 2014 | MED | Chief Executive Officer | Returned to the company | 180,000 | 180,322 | SEC | ||
| Jun 17, 2014 | Jun 19, 2014 | MED | Chief Executive Officer | Awarded | 410,000 | 360,322 | SEC | ||
| Mar 25, 2014 | Jun 19, 2014 | MED | Chief Executive Officer | Withheld for tax | 2,334 | $28.97 | $68k | 360,322 | SEC |
| Nov 30, 2011 | Dec 2, 2011 | PAETEC Holding Corp. | Director | Returned to the companyDirector Stock Option | 43,000 | 0 | SEC | ||
| Nov 30, 2011 | Dec 2, 2011 | PAETEC Holding Corp. | Director | Returned to the company | 116,000 | 0 | SEC | ||
| Oct 31, 2011 | Mar 14, 2013 | MED | Director | Awarded | 61,393 | $16.58 | $1M | 132,656 | SEC |
| Oct 31, 2011 | Nov 4, 2011 | OFFICEMAX INC | EVP and President, Contract | Returned to the company | 34,980 | 0 | SEC | ||
| Aug 15, 2011 | Aug 17, 2011 | OFFICEMAX INC | EVP, President of Contract | AwardedEmployee Stock Option (Right to Buy) | 98,540 | 98,540 | SEC | ||
| Aug 15, 2011 | Aug 17, 2011 | OFFICEMAX INC | EVP, President of Contract | Awarded | 34,980 | 34,980 | SEC | ||
| Jun 27, 2011 | Jun 29, 2011 | PAETEC Holding Corp. | Director | AwardedDirector Stock Option | 15,000 | 15,000 | SEC | ||
| Jun 27, 2011 | Jun 29, 2011 | PAETEC Holding Corp. | Director | Awarded | 15,000 | 116,000 | SEC | ||
| Jun 20, 2011 | Jun 22, 2011 | MED | Director | Awarded | 1,393 | $22.40 | $31k | 71,156 | SEC |
| May 27, 2010 | Jun 1, 2010 | PAETEC Holding Corp. | Director | AwardedDirector Stock Option | 5,500 | 5,500 | SEC | ||
| May 27, 2010 | Jun 1, 2010 | PAETEC Holding Corp. | Director | Awarded | 5,500 | 101,000 | SEC | ||
| Apr 27, 2010 | Apr 28, 2010 | PAETEC Holding Corp. | Director | Exercised or settledDirector Stock Option | 4,000 | 8,000 | SEC | ||
| Apr 27, 2010 | Apr 28, 2010 | PAETEC Holding Corp. | Director | Exercised options | 4,000 | $1.58 | $6k | 95,500 | SEC |
| Apr 6, 2010 | Apr 8, 2010 | MED | Director | Awarded | 566 | $26.52 | $15k | 69,763 | SEC |
| Feb 23, 2010 | Feb 25, 2010 | PAETEC Holding Corp. | Director | AwardedDirector Stock Option | 9,500 | 9,500 | SEC | ||
| Feb 23, 2010 | Feb 25, 2010 | PAETEC Holding Corp. | Director | Awarded | 9,500 | 91,500 | SEC | ||
| Jan 22, 2010 | Jan 26, 2010 | PAETEC Holding Corp. | Director | Exercised or settledDirector Stock Option | 25,000 | 0 | SEC | ||
| Jan 22, 2010 | Jan 26, 2010 | PAETEC Holding Corp. | Director | Exercised options | 25,000 | $2.26 | $57k | 82,000 | SEC |
| May 13, 2009 | May 13, 2009 | MED | Director | Returned to the company | 10,000 | $6.59 | $66k | 57,697 | SEC |
| Apr 1, 2009 | Apr 3, 2009 | PAETEC Holding Corp. | Director | AwardedDirector Stock Option | 12,000 | 12,000 | SEC | ||
| Apr 1, 2009 | Apr 3, 2009 | PAETEC Holding Corp. | Director | Awarded | 12,000 | 57,000 | SEC | ||
| Mar 24, 2009 | Mar 26, 2009 | MED | Director | Awarded | 4,000 | $4.23 | $17k | 67,697 | SEC |
| Nov 19, 2008 | Nov 20, 2008 | MED | Director | Gift | 3,422 | $4.00 | $14k | 61,197 | SEC |
| Oct 16, 2007 | Oct 18, 2007 | PAETEC Holding Corp. | Director, 10% owner | AwardedDirector Stock Option | 5,000 | 5,000 | SEC |
Page 1
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2020 | Oct 2, 2020 | MED | Director | Form 4 sale | 5,000 | $827k | 1.8% | Plan not stated | SEC |
| Jul 1, 2020 | Jul 6, 2020 | MED | Director | Form 4 sale | 5,000 | $694k | 1.8% | Plan not stated | SEC |
| May 6, 2020 | May 8, 2020 | MED | Director | Form 4 sale | 10,000 | $1M | 3.5% | Plan not stated | SEC |
| Mar 5, 2019 | Mar 7, 2019 | MED | Director | Form 4 sale | 18,825 | $2.5M | 100.0% | Unusual | SEC |
| Mar 9, 2018 | Mar 13, 2018 | MED | Director | Form 4 sale | 40,000 | $3.5M | 11.3% | Plan not stated | SEC |
| May 1, 2007 | May 2, 2007 | XEROX CORP | Senior Vice President | Form 4 sale | 33,100 | $610k | 59.7% | Unusual | SEC |
| Feb 5, 2007 | Feb 6, 2007 | XEROX CORP | Senior Vice President | Form 4 sale | 20,000 | $346k | 47.3% | Unusual | SEC |
| Aug 4, 2006 | Aug 7, 2006 | XEROX CORP | Senior Vice President | Form 4 sale | 16,000 | $227k | 27.4% | Unusual | SEC |
| Jan 30, 2006 | Feb 1, 2006 | XEROX CORP | Senior Vice President | Form 4 sale | 44,000 | $616k | 43.0% | Unusual | SEC |